LRCX vs META: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

Both stocks have similar AI ratings. Review detailed metrics below.

LRCX
LAM RESEARCH CORP
BUY
86%
Confidence
VS
META
Meta Platforms, Inc.
BUY
86%
Confidence

LRCX vs META Fundamental Comparison

Metric LRCX META
Revenue $16.5B $56.3B
Net Income $5.0B $26.8B
Net Margin 30.2% 47.5%
ROE 47.1% 11.0%
ROA 24.0% 6.8%
Current Ratio 2.54x 2.35x
Debt/Equity 0.35x 0.24x
EPS $3.95 $10.44

Green = Better metric | Red = Weaker metric

View Full LRCX Analysis →
View Full META Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

LRCX vs AAPL META vs MSFT LRCX vs GOOGL META vs AMZN

LRCX vs META: Frequently Asked Questions

Is LRCX or META a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. LRCX is rated BUY (86% confidence) while META is rated BUY (86% confidence). This is not investment advice.

How does LRCX compare to META fundamentally?

LAM RESEARCH CORP has ROE of 47.1% vs Meta Platforms, Inc.'s 11.0%. Net margins are 30.2% vs 47.5% respectively.

Which stock pays higher dividends, LRCX or META?

LRCX has a dividend yield of N/A or no dividend while META has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in LRCX or META for long term?

For long-term investing, consider that LRCX has BUY rating with 86% confidence, while META has BUY rating with 86% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about LRCX vs META?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LRCX vs META, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.